Entrez Id: |
629 |
Gene Symbol: |
CFB |
CFB
|
0.400 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
26191 |
Gene Symbol: |
PTPN22 |
PTPN22
|
0.200 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
HLA-DQA1
|
0.200 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
3105 |
Gene Symbol: |
HLA-A |
HLA-A
|
0.190 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
10318 |
Gene Symbol: |
TNIP1 |
TNIP1
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
717 |
Gene Symbol: |
C2 |
C2
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
PSORS1C1
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
4855 |
Gene Symbol: |
NOTCH4 |
NOTCH4
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
7918 |
Gene Symbol: |
GPANK1 |
GPANK1
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
414778 |
Gene Symbol: |
HCG17 |
HCG17
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
23 |
Gene Symbol: |
ABCF1 |
ABCF1
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
5460 |
Gene Symbol: |
POU5F1 |
POU5F1
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
80352 |
Gene Symbol: |
RNF39 |
RNF39
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
57176 |
Gene Symbol: |
VARS2 |
VARS2
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
56244 |
Gene Symbol: |
BTNL2 |
BTNL2
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
10255 |
Gene Symbol: |
HCG9 |
HCG9
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
389376 |
Gene Symbol: |
SFTA2 |
SFTA2
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
LINC00243
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
6941 |
Gene Symbol: |
TCF19 |
TCF19
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
TSBP1-AS1
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
30834 |
Gene Symbol: |
ZNRD1 |
ZNRD1
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
8859 |
Gene Symbol: |
STK19 |
STK19
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
HLA-DQA2
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
135656 |
Gene Symbol: |
MUCL3 |
MUCL3
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
Entrez Id: |
2550 |
Gene Symbol: |
GABBR1 |
GABBR1
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |